Conor Benn in a drug test “against” Chris Eubank Jr. before the fight

Benn is set to fight Eubank at the O2 Arena

Conor Benn has returned a “damaging analytical finding of traces of a fertility drug” ahead of his fight with Chris Eubank Jr, promoters have said.

They say he is not suspended and remains free to fight in London.

“Sample B has not yet been tested, meaning no violations have been confirmed,” said a statement from Matchroom and Wasserman Boxing.

He added that Benn, 26, has not been charged and that he and Eubank, 33, are still looking forward to fighting on Saturday.

The pair will meet in an all-British bantamweight fight at the O2 Arena, 30 years after fathers Nigel Benn and Chris Eubank Sr faced each other in the ring.

A statement from the promoters said: “We are informed that a random anti-doping test carried out by the Voluntary Anti-Doping Association on Conor Benn returned an adverse analytical finding of trace amounts of a fertility drug.

“Mr Benn has passed a doping control test conducted by the UK Anti-Doping Agency, the anti-doping authority to which the British Boxing Control Board has delegated doping control testing. Mr Benn has passed all doping control tests. Conducted by UKAD.

“Both fighters have taken medical and legal advice, are aware of the relevant information and intend to continue their fight this Saturday.”

Benn tested positive for female fertility drug clomiphene in late August or early September, said Kalle Sauerland of Wasserman Boxing, the promoters representing Eubank.

The drug, also known as clomiphene, is on the World Anti-Doping Agency’s list of banned substances.

Sauerland told TalkSport that he didn’t consider it a performance-enhancing drug, but said it “can raise testosterone.”

“We immediately discussed with our most important side, the athlete,” he said.

“He happily followed through and spoke to Ben directly.”

Around the BBC - SoundsAround the foot of the BBC - Sounds